Circulating tumour-derived predictive biomarkers in oncology.
Drug Discov Today
; 15(3-4): 98-101, 2010 Feb.
Article
em En
| MEDLINE
| ID: mdl-20045486
ABSTRACT
Molecular characterization of tumour material will become increasingly important in selecting patients for clinical trials and offering appropriate treatment for patients in clinical practice. Recent advances in the field have indicated that the molecular characteristics of a tumour can be determined from circulating tumour cells and circulating tumour DNA; thus, a simple blood sample could provide these data in a simple, convenient and efficient manner. This article discusses progress towards guiding treatment decisions through measuring tumour-derived factors in the circulation.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
DNA de Neoplasias
/
Biomarcadores Tumorais
/
Neoplasias
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Drug Discov Today
Assunto da revista:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Ano de publicação:
2010
Tipo de documento:
Article
País de afiliação:
Reino Unido